The Clinical Efficacy Of Biologic Mesh And Synthetic Mesh For Pelvic Floor Reconstructive Surgery

T. Cao,X. Yang,X. Sun,W. Cheng,J. Wang
DOI: https://doi.org/10.13390/j.issn.1672-1861.2017.02.004
2017-01-01
Abstract:Objective To compare clinical efficacy of biologic mesh and synthetic mesh in treatment of pelvic organ prolapse(POP).Methods 96 patients with POP at more than Ⅱ of POP quantitation (POP-Q) staging system undergoing pelvic reconstructive surgery were selected and divided into two groups.Each group has 48 cases.One group was treated with Surgisis and the other was Avaulta.The perioperative,operative and postoperative data were compared.Fesults The average ofoperation time in Surgisis group was (126.4 ± 39.8)min,which was significantly more than the Avaulta.The average amount of bleeding volume in Surgisis [(130.5 ± 98.4) ml]and Avaulta [(30.5 ± 10.1) ml] had significant difference.while the postoperative temperature,urine tube indwelling time,residual urine volume of the two groups had no difference (P > 0.05).At one-year follow up,the objective recurrence rate of Surgisis group is higher (25.0% vs 8.3%),but the subjective recurrence rate is lower (6.3%).After operation,the quality of life in two groups was largely improved.Comparing the sexual quality of life,the score of Surgisis group was higher than that in Avaulta (P < 0.05).There was no mesh exposure in Surgisis group,while four patients had mesh erosion in Avaulta group.They all underwent surgery.Conclusions Comparing the synthetic mesh,biologic mesh in pelvic floor reconstructive surgery can improve the quality of life,reducing the occurrence of complications,although it takes longer time and more intraoperative blood loss in surgery.
What problem does this paper attempt to address?